- Bacterial resistance to antimicrobial agents: an overview from Korea
-
Kim WJ, Park SC
- KMID: 711589
- Yonsei Med J.
- 1998 Dec;39(6):488-494.
- doi: 10.3349/ymj.1998.39.6.488
Antimicrobial resistance of bacteria has become a worldwide problem. Available data suggest that the resistance problem is comparatively more serious in Korea. In large hospitals, the proportion of methicillin-resistant Staphylococcus... -
- CITED
-
- Close
- SHARE
-
- Close
- A Comparison of Clinical Features and Mortality among Methicillin-Resistant and Methicillin-Sensitive Strains of Staphylococcus aureus Endocarditis
-
Yoon HJ, Choi JY, Kim CO, Kim JM, Song YG
- KMID: 1716519
- Yonsei Med J.
- 2005 Aug;46(4):496-502.
- doi: 10.3349/ymj.2005.46.4.496
Our objective was to assess the clinical factors that would reliably distinguish methicillin-resistant S. aureus (MRSA) from methicillin-susceptible S. aureus (MSSA) endocarditis. A retrospective cohort study of clinical features and... -
- CITED
-
- Close
- SHARE
-
- Close
- Agranulocytosis Induced by Vancomycin in an ESRD Patient on CAPD
-
Jo YI, Yoon JH, Shin SY, Chang WC, Kim BK, Jin CJ, Song JO
- KMID: 759687
- Korean J Intern Med.
- 2004 Mar;19(1):58-61.
Agranulocytosis is a rare adverse effect associated with prolonged vancomycin therapy, and is potentially serious, especially in end stage renal disease (ESRD) patients. We describe a continuous ambulatory peritoneal dialysis... -
- CITED
-
- Close
- SHARE
-
- Close
- Antibiotic resistance and molecular characterization of ophthalmic Staphylococcus pseudintermedius isolates from dogs
-
Kang MH, Chae MJ, Yoon JW, Kim SG, Lee SY, Yoo JH, Park HM
- KMID: 2155624
- J Vet Sci.
- 2014 Sep;15(3):409-415.
- doi: 10.4142/jvs.2014.15.3.409
The prevalence, virulence potential, and antibiotic resistance of ophthalmic Staphylococcus pseudintermedius (SP) isolated from dogs were examined. Sixty-seven Staphylococcus species were isolated from ophthalmic samples and surveyed for species-specific sequences... -
- CITED
-
- Close
- SHARE
-
- Close
- Synergy of Arbekacin-based Combinations Against Vancomycin Hetero-intermediate Staphylococcus aureus
-
Lee JY, Oh WS, Ko KS, Heo ST, Moon CS, Ki HK, Kiem S, Peck KR, Song JH
- KMID: 1781820
- J Korean Med Sci.
- 2006 Apr;21(2):188-192.
- doi: 10.3346/jkms.2006.21.2.188
This study was undertaken to evaluate the in vitro activities of arbekacin-based combination regimens against vancomycin hetero-intermediate Staphylococcus aureus (hetero-VISA). Combinations of arbekacin with vancomycin, rifampin, ampicillin-sulbactam, teicoplanin, or quinipristin-dalfopristin... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical and Microbiological Characteristics of Six Staphylococcus pettenkoferi Isolates From Blood Samples
-
Park S, Chung HS, Lee M
- KMID: 2363188
- Ann Lab Med.
- 2015 Mar;35(2):250-253.
- doi: 10.3343/alm.2015.35.2.250
Coagulase-negative staphylococci (CoNS) are reported to be the leading cause of nosocomial bloodstream infections. Staphylococcus pettenkoferi is a novel member of CoNS that was first isolated from the human blood... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk Factors for Fluoroquinolone Resistance in Ocular Cultures
-
Lee J, Choi S
- KMID: 2360132
- Korean J Ophthalmol.
- 2015 Feb;29(1):7-13.
- doi: 10.3341/kjo.2015.29.1.7
PURPOSE: To identify the risk factors associated with fluoroquinolone resistance in patients undergoing cataract surgery. METHODS: A total of 1,125 patients (1,125 eyes) who underwent cataract surgery at Veterans Health Service... -
- CITED
-
- Close
- SHARE
-
- Close
- Teicoplanin Dosing Strategy for Treatment of Staphylococcus aureus in Korean Patients with Neutropenic Fever
-
Ahn BJ, Yim DS, Lee DG, Kwon JC, Kim SH, Choi SM
- KMID: 1727994
- Yonsei Med J.
- 2011 Jul;52(4):616-623.
- doi: 10.3349/ymj.2011.52.4.616
PURPOSE: The present study was conducted to determine and compare the target attainment rate (TAR) between microorganism-nonspecific (Ctrough) and microorganism-specific (AUC24/MIC) targets over two weeks of teicoplanin administration according to... -
- CITED
-
- Close
- SHARE
-
- Close
